Paris - Delayed Quote • EUR
Advicenne S.A. (ALDVI.PA)
As of 10:06 AM GMT+2. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -0.64 | 2.06 |
| Low Estimate | 0 | 0 | -0.64 | 2.06 |
| High Estimate | 0 | 0 | -0.64 | 2.06 |
| Year Ago EPS | -- | -- | -0.67 | -0.64 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 4.2M | 5.5M |
| Low Estimate | -- | -- | 4.2M | 5.5M |
| High Estimate | -- | -- | 4.2M | 5.5M |
| Year Ago Sales | -- | -- | 3.48M | 4.2M |
| Sales Growth (year/est) | -- | -- | 20.60% | 31.00% |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.64 | 2.06 |
| 7 Days Ago | 0 | 0 | -0.64 | 2.06 |
| 30 Days Ago | 0 | 0 | -0.64 | 2.06 |
| 60 Days Ago | 0 | 0 | -0.65 | 0.78 |
| 90 Days Ago | 0 | 0 | -0.72 | 0.7 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ALDVI.PA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 7.90% |
| Next Qtr. | -- | -- | -- | 10.20% |
| Current Year | 4.50% | -- | -- | 4.80% |
| Next Year | 421.90% | -- | -- | 12.50% |
| Next 5 Years (per annum) | -- | -- | -- | 11.27% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
No Fair Value available for this ticker
Related Tickers
PRTC PureTech Health plc
29.50
-2.66%
MEDCL.PA MedinCell S.A.
15.30
+0.92%
OXUR.BR Oxurion NV
0.0001
0.00%
PEPG PepGen Inc.
14.50
-0.41%
OSE.PA OSE Immunotherapeutics SA
8.12
+4.24%
MNOV MediciNova, Inc.
1.3206
-1.45%
GNFT.PA Genfit S.A.
4.6750
+9.10%
AKTX Akari Therapeutics, Plc
1.8337
-5.48%
APS.TO Aptose Biosciences Inc.
1.5700
-2.48%
IFRX InflaRx N.V.
1.4600
+1.39%